STOCK TITAN

Cero Therapeutics (NASDAQ: CERO) holder Isaiah Tibbs reports 8.67% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

CERO THERAPEUTICS HOLDINGS, INC. reports that Isaiah Tibbs beneficially owns 1,830,007 shares of Common Stock, representing 8.67% of the class. The filing states Tibbs has sole power to vote and sole dispositive power over all 1,830,007 shares.

Positive

  • None.

Negative

  • None.

Insights

Beneficial owner now holds a significant minority stake with sole voting control.

The filing identifies 1,830,007 shares and 8.67% ownership with sole voting and dispositive power. This level creates a visible holder with unilateral voting control over those shares, which could matter for proxy dynamics.

Stake implications depend on future disclosures of related agreements or additional filings; subsequent filings would clarify intent or coordination with other holders.

Schedule 13G disclosure documents passive beneficial ownership above the 5% threshold.

The report lists the holder, address, class (Common Stock), and CUSIP 15687V102. The filing format signals disclosure of beneficial ownership consistent with Section 13 rules rather than an active solicitation.

Regulatory follow-up would occur if ownership crosses other thresholds or the holder changes status; no such changes are disclosed here.






02/19/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Tibbs Isaiah
Signature:Tibbs Isaiah
Name/Title:Individual
Date:03/12/2026

FAQ

What does the Schedule 13G filed for CERO reveal about Isaiah Tibbs' holdings?

It discloses 1,830,007 shares of Common Stock, representing 8.67% of the class. The filing records sole voting and sole dispositive power over those shares and cites CUSIP 15687V102.

Does the filing show whether Tibbs shares voting power with others for CERO?

No; the Schedule 13G states Tibbs has sole voting power of 1,830,007 shares and shared voting power of 0. The filing therefore reports unilateral voting control over the disclosed position.

Is the Tibbs position in CERO a majority or minority stake?

It is a minority stake. The filing reports Tibbs beneficially owns 1,830,007 shares, which the document lists as 8.67% of the outstanding class of Common Stock.

What class and CUSIP are associated with the disclosed CERO shares?

The filing lists the security as Common Stock and provides CUSIP 15687V102. These identifiers are included alongside the beneficial ownership and voting power disclosures.

Who signed the ownership disclosure for CERO and how is control described?

The signature block lists the reporting person as Isaiah Tibbs signing the form. The disclosure states Tibbs has sole power to vote and sole power to dispose of the 1,830,007 shares.
CERo Therapeutics

OTC:CERO

View CERO Stock Overview

CERO Rankings

CERO Latest News

CERO Latest SEC Filings

CERO Stock Data

177.38k
21.07M
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO